Treatment of vaginal Candida infections

Bibliography

• BERG AO, HEIDRICH RD, FIHN SD et al.: Establishing the cause of symptoms in women in a family practice. JAMA (1984) 251:620–625.
   PubMed Web of Science ®Google Scholar
• ODDS FC: Candidosis Of The Genitalia In Candida And Candidosis. A Review And Bibliography (2nd ed.). Bailliere Tindall (1988):124.
   Google Scholar
• FERRIS DG, NYIRJESY P, SOBEL JD, SOPER D, PAVLOTIC A, LITAKER MS: Over-the-counter antifungal drug misuse associated with patient diagnosed vulvovaginal candidiasis. Obstet. Gynecol (2002). In press.
   Google Scholar
• REED BD: Risk factors for Candida vulvovaginitis. Obstet. Gynecol Surv. (1992) 47:551–560.
   PubMedGoogle Scholar
• HURLEY R, DE LOUVOIS J: Candida vaginitis. Postgrad. Med. 1 (1979) 55:645-647.
   Google Scholar
• HURLEY R: Inveterate vaginal thrush. Practitioner (1975) 215:753–756.
   PubMedGoogle Scholar
• DEPARTMENT OF HEALTH AND SOCIAL SECURITY: Annual Reports of Chief Medical Officer, 1976–1984. England and Wales.
   Google Scholar
• CENTERS FOR DISEASE CONTROL: Non-reported sexually transmitted diseases. MMWR Morb. Mort. Wkly Rep. (1979) 38:61.
   Google Scholar
• FLEURY FJ: Adult vaginitis. Clin. Obstet. Gynecol (1981) 24:407–438.
   PubMedGoogle Scholar
• CHOW AW, PERCIVAL-SMITH R, BARTLETT KH, GOLDRING AM, MORRISON BJ: Vaginal colonization with Escherichia coliin healthy women. Determination of relative risks by quantitative cultures and multivariate statistical analysis. Am. J. Obstet. Gynecol (1986) 154:120–126.
   Google Scholar
• GOLDACRE MJ, WATT B, LOUDON N, MILNE LJ, LOUDON JD, VESSEY MP: Vaginal microbial flora in normal young women. Br. Med. 1 (1979) 1(6176):1450–1455.
   Google Scholar
• SOBEL JD: Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol (1985) 152:924–935.
   PubMed Web of Science ®Google Scholar
• CAUVVENBERGH G: Vaginal candidiasis: Evolving trends in the incidence and treatment on non- Candida albicans infection. Can: Pro& Obstet. Gyncol Fertil (1990) 8: 41.
   Google Scholar
• HOROWITZ BJ, GIAQUINTA D, ITO S: Evolving pathogens in vulvovaginal candidiasis: implications for patient care. Pharmacol (1992) 32:248–255.
   Google Scholar
• COTCH ME HILLIER SL, GIBBS RS et al.: Vaginal carriage of Candida sp. in pregnancy. Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL, USA (29 September 1991). Abstract 1251:307.
   Google Scholar
• SOBEL JD, BROOKER D, STEIN G et al.: Single oral dose fluconazole compared with conventional topical therapy of Candida vaginitis. Am. j Obstet. Gynecol (1995) 172:1263–1268.
   PubMed Web of Science ®Google Scholar
• SOBEL JD, KAPERNIK P, ZERVOS M et al.: Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am. J. Obstet. Gynecol (2001) 185:363–369.
   PubMed Web of Science ®Google Scholar
• SOBEL JD, OHMIT SE, SCHUMAN P et al.: The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from HIV-seropositive and at-risk seronegative women J. Infect. Dis. (2001) 182:286–293.
   Google Scholar
• VAZQUEZ JA, SOBEL JD, DEMITRIOU R et al.: Karotyping of C. albicans obtained longitudinally in women with recurrent vulvovaginal candidiasis. J. Infect. Dis. (1994) 170:1566–1569.
   Google Scholar
• REEF S, LEVINE WC, MCNEIL MM et al.: Treatment options for vulvovaginal candidiasis background paper for develop-ment of 1993 STD treatment recomm-endations. Gin. Infect. Dis. (1995) 20:80.
   PubMedGoogle Scholar
• WATSON MC, GRIMSHAW JM, BOND CM et al.: Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Review. Cochrane Database Syst. Rev (2001) 4:CD002845.
   Google Scholar
• LYNCH ME, SOBEL JD: Comparative in vitro activity of antimycotic against pathogenic vaginal yeast isolates. J. Med. Vet. Mycol (1994) 32:267–274.
   PubMedGoogle Scholar
• TOOLEY PJ: Patients and doctor preferences in the treatment of vaginal candidiasis. Practitioner (1990) 71:73–76.
   Google Scholar
• LEWIS JH, ZIMMERMAN HJ, BENSON GD, ISHAK KG: Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology (1984) 86:503–513.
   PubMed Web of Science ®Google Scholar
• MOEBIUS UM: Influenza-like syndrome after terconazole. Lancet (1988) 2:966.
   PubMedGoogle Scholar
• SOBEL JD, FARO S, FORCE RW et al.: Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol (1998) 178:203–211.
   PubMed Web of Science ®Google Scholar
• RITTER W: Pharmacolkinetics fundamentals of vaginal treatment with clotrimazole. Am. J. Obstet. Gynecol (1985) 152:945.
   PubMed Web of Science ®Google Scholar
• HOUANG ET, CHAPPATTE 0, BYRNE D, MACRAE PV, THOIPER JG: Fluconazole levels in plasma and vaginal secretion of patients with the 150 mg single dose and rate of eradication of infection in vaginal candidiasis. Antimicrob. Agent Chemother. (1990) 34:409–413.
   PubMedGoogle Scholar
• SOBEL JD: Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet. Gynecol (1985) 65:435–440.
   PubMedGoogle Scholar
• SOBEL JD: Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl. J. Med. (1986) 315:1455–1458.
   Google Scholar
• DAVISON F, MOULD RF: Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br. Vener. Dis. (1978) 54:176–183.
   PubMedGoogle Scholar
• SOBEL JD: Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int. J. Gynecol Obstet. (1992) 37:17.
   Google Scholar
• FONG IW: The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin. Med. (1992) 68:174–176.
   PubMedGoogle Scholar
• SPINILLO A, CARRATTA L, PIZZOLI G et al.: Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. I Reprod. Med. (1992) 37:343–347.
   Google Scholar
• DENNERSTEIN GJ: Depo-provera in the treatment of recurrent vulvovaginal candidiasis. Reprod. Med. (1986) 31:801.
   PubMedGoogle Scholar
• HILTON E, ISENBERG HD, ALPERSTEIN P, FRANCE K, BOWENSTEIN M: Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann. Intern. Med. (1992) 116:353–357.
   PubMed Web of Science ®Google Scholar
• ROSEDALE N, BRAUE K: Hyposensitization in the management of recurring vaginal candidiasis. Ann. Allergy (1979) 43(4):250–253.
   PubMedGoogle Scholar
• NG TT, DENNING DW: Fluconazole resistance in Candida in patients with AIDS: a therapeutic approach. I Infect. (1993) 26:117–125.
   PubMed Web of Science ®Google Scholar
• REDONDO-LOPEZ V, LYNCH M, SCHMITT C, COOK R, SOBEL JD: Torulopsis glabrata vaginitis clinical aspects and susceptibility to antifungal agents. Obstet. Cynecol. (1990) 76:651–655.
   Google Scholar
• SOBEL JD, CHAIM W: Treatment of Candida glabrata vaginitis: a retrospective review of boric acid therapy. Clin. Infect. Dis. (1997) 24:649–652.
   PubMed Web of Science ®Google Scholar
• HOROWITZ B: Topical flucytosine therapy for chronic recurrent Candida tropicalis infections. J. Reprod. Med. (1986) 31:821–824.
   PubMed Web of Science ®Google Scholar
• RHOADS JL, WRIGHT DC, REDFIELD RR, BURKE DS: Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA (1987) 257:3105–3107.
   PubMed Web of Science ®Google Scholar
• IMAN N, CARPENTER CC, MAYER KH, FISHER A, STEIN M, DANFORTH SB: Hierarchial pattern of mucosal Candida infections in HIV seropositive women. Am. J. Med. (1990) 89:142–146.
   PubMedGoogle Scholar
• CARPENTER CJ, MAYER KH, FISHER A et al.: Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am. J. Med. (1989) 86:771–775.
   PubMed Web of Science ®Google Scholar
• WHITE MH: Is vulvovaginal candidiasis an AIDS-related illness? Clin. Infect. Dis. (1996) 22\(Suppl. 2):5124–5127.
   Google Scholar
• SCHUMAN P, SOBEL JD, OHMIT SE et al.: Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis. (1998) 27:1161–1167.
   PubMed Web of Science ®Google Scholar
• DUERR AC, SIERRA ME FELDMAN Jet al.: Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus infected women. Obstet. Cynecol. (1997) 90:1–5.
   Google Scholar
• BURNS DN, TUOMLA R, BEI-HUNG C et al.: Vaginal colonization or infection with Candida albicans in HIV-infected women during pregnancy and during postpartum period. Clin. Infect. Dis. (1997) 24:201–210.
   PubMedGoogle Scholar
• SPINILLO A, MICHELONE G, CAVANN C et al.: Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV seropositive women. Cenitourin. Med. (1994) 70:268–272.
   PubMedGoogle Scholar
• SCHUMAN P, CAPPS L, PENG G et al.:Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. Ann. Intern. Med. (1997) 126:689–696.
   PubMed Web of Science ®Google Scholar
• KAPIGA SH, LYAMUYA EF, LWIHULA GK, HUNTER DJ: The incidence of HIV infection among women using family planning methods in Dares Salaam, Tarzania. AIDS (1998) 12:75–81.
   PubMed Web of Science ®Google Scholar